收藏切换
Research progress on active compounds against pathogenic coronaviruses and their potential target proteins
收藏切换
PDF
Xiao-yu WANG1, 2, Cheng PENG2, 3, Yan-qing YANG2, 3, Yu-long SHI2, 3, Zheng-dan ZHU2, 3, Kai-jie MU2, 3, Hui-yu LI1, *, Zhi-jian XU2, 3, *, Wei-liang ZHU2, 3, *
Acta Pharmaceutica Sinica | 2020, 55(10) : 2340 - 2357
Less
收藏切换
Acta Pharmaceutica Sinica | 2020, 55(10): 2340-2357
Reviews
Research progress on active compounds against pathogenic coronaviruses and their potential target proteins
Full
Xiao-yu WANG1, 2, Cheng PENG2, 3, Yan-qing YANG2, 3, Yu-long SHI2, 3, Zheng-dan ZHU2, 3, Kai-jie MU2, 3, Hui-yu LI1, *, Zhi-jian XU2, 3, *, Wei-liang ZHU2, 3, *
Affiliations
  • 1. College of Mathematics and Physics, Shanghai University of Electric Power, Shanghai 200090, China
  • 2. Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
  • 3. School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China
Published: 2020-10-12 doi: 10.16438/j.0513-4870.2020-0579
Outline
收藏切换

Human pathogenic coronaviruses can be divided into seven types, namely HCoV-229E, HCoV-OC43, HCoV-HKU1, HCoV-NL63, SARS-CoV, MERS-CoV and SARS-CoV-2. Among them, Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and Corona Virus Disease 2019 (COVID-19), which are caused by the last three coronaviruses respectively, are enormous threats that challenge human health and social and economic development. Despite the huge investment in drug development for pathogenic coronaviruses, there is no specifically effective anti-coronavirus drug approved so far. In this review we systematically summarize 146 representative anti-coronavirus active compounds reported in the past 20 years and list 26 potential target proteins involved in the process of viral infection and replication. In addition, we predict the target proteins of those active compounds with unclear antiviral activity mechanisms. We hope that the information will be useful to accelerate the development of new anti-coronavirus drugs.

coronavirus  /  COVID-19  /  target protein  /  active compound  /  drug development
Xiao-yu WANG, Cheng PENG, Yan-qing YANG, Yu-long SHI, Zheng-dan ZHU, Kai-jie MU, Hui-yu LI, Zhi-jian XU, Wei-liang ZHU. Research progress on active compounds against pathogenic coronaviruses and their potential target proteins[J]. Acta Pharmaceutica Sinica, 2020 , 55 (10) : 2340 -2357 . DOI: 10.16438/j.0513-4870.2020-0579
Year 2020 volume 55 Issue 10
PDF
160
70
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-0579
  • Receive Date:2020-04-18
  • Online Date:2026-01-23
  • Published:2020-10-12
Article Data
Affiliations
History
  • Received:2020-04-18
  • Revised:2020-05-31
Funding
Affiliations
    1. College of Mathematics and Physics, Shanghai University of Electric Power, Shanghai 200090, China
    2. Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    3. School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-0579
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT